Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

January 21, 2020

Correspondence response
Response to: ‘Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors’ by Meyer et al
Free

Michelle Rosenzwajg, Roberta Lorenzon, David Klatzmann

doi: 10.1136/annrheumdis-2019-216598

January 20, 2020

Correspondence response
Response to: ‘Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease’ by Campochiaro et al
Free

Fleur Cohen-Aubart, Neila Benameur, Zahir Amoura, Julien Haroche

doi: 10.1136/annrheumdis-2019-216755
Correspondence
Interleukin-4 as an emerging therapeutic target for IgG4-related disease
Free

Mitsuhiro Akiyama, Yuko Kaneko, Tsutomu Takeuchi

doi: 10.1136/annrheumdis-2020-216961
Correspondence response
Response to: ‘“Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation” by Braaten et al: another point of view’ by Cappelli et al
Free

Laura C Cappelli, Clifton O Bingham, Tawnie Braaten, Ami A Shah

doi: 10.1136/annrheumdis-2019-216892

January 14, 2020

Correspondence
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease
Free

Emanuel Della-Torre, Marco Lanzillotta, Mona-Rita Yacoub

doi: 10.1136/annrheumdis-2020-216945

January 10, 2020

Correspondence response
Response to: ‘Causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study’ by Lee
Free

Jun Inamo

doi: 10.1136/annrheumdis-2019-216767
Correspondence
Causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study
Free

Young Ho Lee

doi: 10.1136/annrheumdis-2019-216747
Inflammatory arthritis
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation

Tawnie J Braaten, Julie R Brahmer, Patrick M Forde, Dung Le, Evan J Lipson, Jarushka Naidoo, Megan Schollenberger, Lei Zheng, Clifton O Bingham 3rd, Ami A Shah, Laura C Cappelli

doi: 10.1136/annrheumdis-2019-216109
Letter
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease

Rachel S Simpson, Stephanie Ka Ching Lau, Jason Kihyuk Lee

doi: 10.1136/annrheumdis-2019-216368

January 08, 2020

Systemic lupus erythematosus
Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach

John G Hanly, Murray B Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Ann E Clarke, Daniel J Wallace, David A Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcón, Ronald F van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanc, Kenneth C Kalunian, Søren Jacobsen, Christine A Peschken, Diane L Kamen, Anca Askanase, Vernon Farewell

doi: 10.1136/annrheumdis-2019-216150
Viewpoint
The earlier, the better or the worse? Towards accurate management of patients with arthralgia at risk for RA

Annette van der Helm-van Mil, Robert B M Landewé

doi: 10.1136/annrheumdis-2019-216716
Correspondence response
Enrichment of polyfunctional T cells in PsA synovial tissue. Response to: ‘Polyfunctional TEM cells in psoriatic arthritis synovium skewed towards Th17 cells’ by Raychaudhuri et al
Free

Mary Canavan, Sarah M Wade, Douglas J Veale, Ursula Fearon

doi: 10.1136/annrheumdis-2019-216814

January 06, 2020

Correspondence
'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation’ by Braaten et al: another point of view
Free

Fulvia Ceccarelli, Andrea Botticelli, Alain Jonathan Gelibter, Ilaria Leccese, Ramona Lucchetti, Enrico Cortesi, Guido Valesini, Paolo Marchetti, Fabrizio Conti

doi: 10.1136/annrheumdis-2019-216867

January 03, 2020

Correspondence response
Response to: ‘Frequency of MRI changes suggestive of axial spondyloarthritis in the axial in a large population-based cohort of individuals aged <45 years’ by Parperis
Free

Xenofon Baraliakos, Adrian Richter, Carsten O Schmidt, Juergen Braun

doi: 10.1136/annrheumdis-2019-216798
Imaging
Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia

Kornelis S M van der Geest, Frances Borg, Abdul Kayani, Davy Paap, Prisca Gondo, Wolfgang Schmidt, Raashid Ahmed Luqmani, Bhaskar Dasgupta

doi: 10.1136/annrheumdis-2019-216343
Letter
Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus

Keisuke Maeshima, Hirotaka Shibata

doi: 10.1136/annrheumdis-2019-216571
Editorial
Chronic inflammatory arthritis following checkpoint inhibitor therapy for cancer: game changing implications
Free

Leonard Calabrese, Xavier Mariette

doi: 10.1136/annrheumdis-2019-216510

December 31, 2019

Rheumatoid arthritis
Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study

Emmanuel Monnet, Ernest H Choy, Iain McInnes, Tamta Kobakhidze, Kathy de Graaf, Philippe Jacqmin, Geneviève Lapeyre, Cristina de Min

doi: 10.1136/annrheumdis-2019-216487
Correspondence response
Response to: ‘response to: irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?’ by Proft et al.
Free

Johan Karlsson Wallman, Elisabeth Mogard, Jan Marsal, Kristofer Andréasson, Anna Jöud, Mats Geijer, Lars Erik Kristensen, Elisabet Lindqvist, Tor Olofsson

doi: 10.1136/annrheumdis-2019-216752
Correspondence
Do we need the PFAPA syndrome in adults with non-monogenic periodic fevers?
Free

Antoine Fayand, Veronique Hentgen, Stephanie Ducharme-Bénard, Pierre Quartier, Brigitte Bader-Meunier, Isabelle Koné-Paut, Gilles Grateau, Sophie Georgin-Lavialle

doi: 10.1136/annrheumdis-2019-216827
Correspondence
Correspondence on ‘Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor’ by Ishikawa et al
Free

Cristina Regueiro, Antonio Gonzalez

doi: 10.1136/annrheumdis-2019-216849

December 23, 2019

Osteoarthritis
Single-cell RNA-seq analysis identifies meniscus progenitors and reveals the progression of meniscus degeneration

Hao Sun, Xingzhao Wen, Hongyi Li, Peihui Wu, Minghui Gu, Xiaoyi Zhao, Ziji Zhang, Shu Hu, Guping Mao, Ruofan Ma, Weiming Liao, Zhiqi Zhang

doi: 10.1136/annrheumdis-2019-215926
Autoimmunity
Germline genetic patterns underlying across familial rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren’s syndrome highlight T cell-initiated autoimmunity

Yukai Wang, Shaoqi Chen, Jingyao Chen, Xuezhen Xie, Sini Gao, Chengpeng Zhang, Songxia Zhou, Jing Wang, Ruiqin Mai, Qisheng Lin, Jianqun Lin, Marco Matucci-Cerinic, Guohong Zhang, Daniel E Furst

doi: 10.1136/annrheumdis-2019-215533
Systemic lupus erythematosus
IFN-α kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study

Frederic A Houssiau, Aikaterini Thanou, Minodora Mazur, Edgar Ramiterre, Danny Alexis Gomez Mora, Maria Misterska-Skora, Risto Alfredo Perich-Campos, Svetlana A Smakotina, Sergio Cerpa Cruz, Bassem Louzir, Thérèse Croughs, Michael Lucas Tee

doi: 10.1136/annrheumdis-2019-216379

December 20, 2019

Correspondence response
Response to: ‘Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus’ by Wang et al
Free

Martin Aringer, Karen Costenbader, Thomas Dörner, Sindhu R Johnson

doi: 10.1136/annrheumdis-2019-216807
Correspondence
Polyfunctional TEM cells in psoriatic arthritis synovium skewed towards Th17 cells
Free

Smriti K Raychaudhuri, Christine Abria, Siba P Raychaudhuri

doi: 10.1136/annrheumdis-2019-216658
Correspondence response
Response to: ‘New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion’ by Sacre et al
Free

Martin Aringer, Karen Costenbader, Thomas Dörner, Sindhu R Johnson

doi: 10.1136/annrheumdis-2019-216803

December 19, 2019

Letter
Not only synovitis but also tenosynovitis needs to be considered: why it is time to update textbook images of rheumatoid arthritis

Cleo Rogier, Silvia Hayer, Annette van der Helm-van Mil

doi: 10.1136/annrheumdis-2019-216350

December 18, 2019

Correspondence response
Paradox of circulating TRMs. Response to: ‘Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients’ by Guggino et al
Free

Zoya Qaiyum, Eric Gracey, YuChen Yao, Robert D Inman

doi: 10.1136/annrheumdis-2019-216472
Systemic lupus erythematosus
Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial

Alexis Mathian, Micheline Pha, Julien Haroche, Fleur Cohen-Aubart, Miguel Hié, Marc Pineton de Chambrun, Thi Huong Du Boutin, Makoto Miyara, Guy Gorochov, Hans Yssel, Patrick Cherin, Hervé Devilliers, Zahir Amoura

doi: 10.1136/annrheumdis-2019-216303
Correspondence
Response to: ‘Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?’ by Wallman et al
Free

Fabian Proft, Mikhail Protopopov, Valeria Rios Rodriguez, Murat Torgutalp, Britta Siegmund, Denis Poddubnyy

doi: 10.1136/annrheumdis-2019-216735
Letter
LRBA deficiency: a new genetic cause of monogenic lupus

Bernadete L Liphaus, Iris Caramalho, Andreia Rangel-Santos, Clóvis A Silva, Jocelyne Demengeot, Magda Maria Salles Carneiro-Sampaio

doi: 10.1136/annrheumdis-2019-216410
Correspondence response
Response to: ‘Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares’ by Didierlaurent et al
Free

Chio Yokose, Hyon Choi

doi: 10.1136/annrheumdis-2019-216670
Osteoarthritis
Interleukin 1 receptor antagonist (IL1RN) gene variants predict radiographic severity of knee osteoarthritis and risk of incident disease

Mukundan Attur, Hua Zhou, Johathan Samuels, Svetlana Krasnokutsky, Michelle Yau, Jose U Scher, Michael Doherty, Anthony G Wilson, Jenny Bencardino, Marc Hochberg, Joanne M Jordan, Braxton Mitchell, Virginia B Kraus, Steven B Abramson

doi: 10.1136/annrheumdis-2019-216055

December 17, 2019

Systemic lupus erythematosus
Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus

Maria Grigoriou, Aggelos Banos, Anastasia Filia, Pavlos Pavlidis, Stavroula Giannouli, Vassiliki Karali, Dionysis Nikolopoulos, Antigone Pieta, George Bertsias, Panayotis Verginis, Ioannis Mitroulis, Dimitrios T Boumpas

doi: 10.1136/annrheumdis-2019-215782

December 13, 2019

Correspondence
Frequency of MRI changes suggestive of axial spondyloarthritis in the axial skeleton in a large population-based cohort of individuals aged <45 years
Free

Konstantinos Parperis

doi: 10.1136/annrheumdis-2019-216773
Letter
Risk of malignancy in patients treated for systemic necrotising vasculitis

Antoine Lafarge, Adrien Joseph, Christian Pagnoux, Xavier Puechal, Pacal Cohen, Maxime Samson, Mohamed Hamidou, Alexandre Karras, Matthieu Groh, Thomas Quemeneur, Camillo Ribi, Luc Mouthon, Loic Guillevin, Benjamin Terrier on behalf of the French Vasculitis Study Group (FVSG)

doi: 10.1136/annrheumdis-2019-216452

December 12, 2019

Correspondence response
Limited role of specificity of ANA for SLE classification. Response to: ‘European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist's point of view’ by Infantino et al
Free

Martin Aringer, Karen H Costenbader, Thomas Dörner, Sindhu R Johnson

doi: 10.1136/annrheumdis-2019-216700

December 11, 2019

Correspondence response
Response to: ‘Correspondence to ‘Slope sign’: a feature of large vessel vasculitis?’ by Milchert et al
Free

Alwin Sebastian, Abdul Kayani, Bhaskar Dasgupta

doi: 10.1136/annrheumdis-2019-216690
Systemic lupus erythematosus
High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus

Sarah Reid, Andrei Alexsson, Martina Frodlund, David Morris, Johanna K Sandling, Karin Bolin, Elisabet Svenungsson, Andreas Jönsen, Christine Bengtsson, Iva Gunnarsson, Vera Illescas Rodriguez, Anders Bengtsson, Sabine Arve, Solbritt Rantapää-Dahlqvist, Maija-Leena Eloranta, Ann-Christine Syvänen, Christopher Sjöwall, Timothy James Vyse, Lars Rönnblom, Dag Leonard

doi: 10.1136/annrheumdis-2019-216227

December 09, 2019

Correspondence response
Response to: ‘Comment on ‘Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial’ by Tanaka et al’ by Berkhout et al
Free

Yoshiya Tanaka, Koji Oba, Tsutomu Takeuchi

doi: 10.1136/annrheumdis-2019-216593
Letter
Rapamycin prevents the impairments of social recognition induced by anti-P antibody in a murine model

Xuejiao Wang, Pingting Yang, Ling Qin

doi: 10.1136/annrheumdis-2019-216563
Systemic sclerosis
Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension

Panagiota Xanthouli, Suzana Jordan, Nicklas Milde, Alberto Marra, Norbert Blank, Benjamin Egenlauf, Matthias Gorenflo, Satenik Harutyunova, Hanns-Martin Lorenz, Christian Nagel, Vivienne Theobald, Mona Lichtblau, Charlotte Berlier, Silvia Ulrich, Ekkehard Grünig, Nicola Benjamin, Oliver Distler

doi: 10.1136/annrheumdis-2019-216476
Correspondence
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease
Free

Corrado Campochiaro, Giulio Cavalli, Nicola Farina, Alessandro Tomelleri, Giacomo De Luca, Lorenzo Dagna

doi: 10.1136/annrheumdis-2019-216610
Correspondence response
Response to: ‘NCF1-339 polymorphism and systemic lupus erythematosus’ by Joob and Wiwanitkit
Free

Carl Petrus Linge, Anders Bengtsson

doi: 10.1136/annrheumdis-2019-216669

December 06, 2019

Letter
LACC1 gene mutation in three sisters with polyarthritis without systemic features

Ankita Singh, Deepti Suri, Pandiarajan Vignesh, Gummadi Anjani, Prince Jacob, Katta M Girisha

doi: 10.1136/annrheumdis-2019-216263
Crystal arthropathies
Development of a prediction model for inpatient gout flares in people with comorbid gout

Kanon Jatuworapruk, Rebecca Grainger, Nicola Dalbeth, William J. Taylor

doi: 10.1136/annrheumdis-2019-216277
Correspondence
Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus
Free

Bin Wang, Shiju Chen, Qing Zheng, Zhenyu Gao, Rongjuan Chen, Jingxiu Xuan, Yuan Liu, Guixiu Shi

doi: 10.1136/annrheumdis-2019-216695
Correspondence
New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion
Free

Karim Sacre, Laure Delaval, Antoine Dossier, Jean-Francois Alexandra, Marie Berleur, Marie-Paule Chauveheid, Gregory Ducrocq, Tiphaine Goulenok, Damien van Gysel, Diane Rouzaud, Thomas Papo

doi: 10.1136/annrheumdis-2019-216712

December 04, 2019

Correspondence response
Response to: ‘Association between osteoporosis and statin therapy: the story continues’ by Burden and Weiler
Free

Michael Leutner, Caspar Matzhold, Luise Bellach, Carola Deischinger, Jürgen Harreiter, Stefan Thurner, Peter Klimek, Alexandra Kautzky-Willer

doi: 10.1136/annrheumdis-2019-216627

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

January 21, 2020

January 20, 2020

January 14, 2020

January 10, 2020

January 08, 2020

January 06, 2020

January 03, 2020

December 31, 2019

December 23, 2019

December 20, 2019

December 19, 2019

December 18, 2019

December 17, 2019

December 13, 2019

December 12, 2019

December 11, 2019

December 09, 2019

December 06, 2019

December 04, 2019

Pages